Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2015 | $3,701,242 | | tax credit/rebate |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2016 | $4,515,115 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $83,752 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $39,409 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $39,219 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $39,219 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $47,739 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $110,366 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $302,558 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $581,555 | | tax credit/rebate |
BioLife Plasma Services L.P. | Takeda Pharmaceutical | Idaho | state | 2011 | $523,620 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2010 | $50,000 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2005 | undisclosed | | tax credit/rebate |
Andrx Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | Florida | state | 2003 | undisclosed | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | | tax credit/rebate |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
Bausch & Lomb Incorporated - Clearwater Facility | Bausch Health | Florida | state | 2005 | $135,000 | | tax credit/rebate |
Genzyme Corporation | Sanofi | Florida | state | 2010 | $524,000 | | tax credit/rebate |
Schering Corporation | Merck | Florida | state | 2007 | $84,000 | | tax credit/rebate |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $500,000 | | tax credit/rebate |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | | grant |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $1,200,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $2,779,200 | | tax credit/rebate |
Lupin, Inc. | Lupin Limited | Florida | state | 2014 | $252,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $3,500,000 | | grant |
Johnson and Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2014 | $1,300,000 | | grant |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | local | 2016 | $7,100,000 | | grant |
Buasch & Lomb | Bausch Health | Florida | local | 2005 | $4,795 | | grant |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2016 | $1,000,000 | | grant |
Johnson & Johnson Consumer Inc. | Johnson & Johnson | Florida | state | 2018 | $175,000 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2013 | undisclosed | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2015 | undisclosed | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | local | 2021 | $7,000,000 | | grant |
Intervet | Merck | Delaware | state | 2003 | $19,925 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2005 | $14,972 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2006 | $16,820 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2006 | $21,485 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2007 | $6,650 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2007 | $43,943 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2008 | $16,264 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2008 | $45,400 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2009 | $7,195 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2010 | $47,404 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2011 | $29,450 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2012 | $20,276 | | training reimbursement |
AstraZeneca | AstraZeneca | Delaware | multiple | 1999 | $178,000,000 | | MEGADEAL |
AstraZeneca Pharmaceuticals | AstraZeneca | Delaware | state | 2016 | $5,868 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2013 | $16,236 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2015 | $29,352 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2016 | $28,919 | | training reimbursement |
Incyte Corporation | Incyte Corp. | Delaware | state | 2012 | $11,120,505 | | grant/loan hybrid program |
Protein Sciences Corporation/MEDCO | Sanofi | Connecticut | state | 1992 | $2,099,074 | | grant/loan hybrid program |
Purdue Pharma, LP | Purdue Pharma | Connecticut | state | 2001 | $3,000,000 | | grant/loan hybrid program |
Pfizer Central Research | Pfizer | Connecticut | state | 2000 | $5,000,000 | | grant |
Alexion Pharmaceuticals | AstraZeneca | Connecticut | state | 2012 | $51,000,000 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Connecticut | state | 2012 | $344,500 | | tax credit/rebate |
Boehringer Ingelheim USA Corporation | Boehringer Ingelheim | Connecticut | state | 2012 | $98,000 | | tax credit/rebate |
Alexion Pharmaceuticals, Inc | AstraZeneca | Connecticut | state | 2013 | $26,000,000 | | grant/loan hybrid program |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $2,250,000 | | grant/loan hybrid program |
Pfizer | Pfizer | Connecticut | multiple | 1998 | $60,000,000 | | MEGADEAL (Archived) |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $8,000 | | tax credit/rebate |
Alexion Pharmaceuticals, Inc. | AstraZeneca | Connecticut | state | 2016 | $25,000,000 | | tax credit/rebate |
Hospira Inc. | Pfizer | Colorado | state | 2014 | $31,104 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2020 | $95,736 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $77,030 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $19,850 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $23,110 | | training reimbursement |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
NEUTROGENA CORPORATION | Johnson & Johnson | California | state | 2003 | $202,588 | | training reimbursement |
WATSON PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | California | state | 2005 | $32,240 | | training reimbursement |
DEY, L.P. | Viatris | California | state | 2005 | $121,613 | | training reimbursement |
IDEXX LABORATORIES, INC. | IDEXX Laboratories | California | state | 2006 | $36,530 | | training reimbursement |
VISX INCORPORATED | Abbott Laboratories | California | state | 2006 | $59,748 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2006 | $439,595 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2007 | $359,454 | | training reimbursement |
GENENTECH, INC. | Roche | California | state | 2007 | $602,758 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $143,620 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2009 | $536,590 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2010 | $843,336 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2010 | $1,470,600 | | training reimbursement |
VISX, Inc | Abbott Laboratories | California | state | 2004 | undisclosed | | training reimbursement |
Hospira, Inc | Pfizer | California | state | 2007 | undisclosed | | training reimbursement |
Millipore, Inc. | Merck KGaA (EMD) | California | state | 2007 | undisclosed | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | California | state | 2009 | undisclosed | | training reimbursement |
MILLIPORE CORPORATION | Merck KGaA (EMD) | California | state | 2011 | $59,646 | | training reimbursement |
GILEAD SCIENCES, INC. | Gilead Sciences | California | state | 2011 | $190,995 | | training reimbursement |
IMPAX LABORATORIES, INC. | Amneal Pharmaceuticals | California | state | 2011 | $195,440 | | training reimbursement |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2011 | $209,316 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | undisclosed | | training reimbursement |
AMYRIS, INC. | Amyris | California | state | 2012 | $99,927 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | $249,570 | | training reimbursement |
C3I, INC | Merck | California | local | 2012 | undisclosed | | tax credit/rebate |
KITE PHARMA INC | Gilead Sciences | California | local | 2012 | undisclosed | | tax credit/rebate |
MEDICIS THE DERMATOLOGY CO | Bausch Health | California | local | 2012 | undisclosed | | tax credit/rebate |